Publications
141
Citations
6,635
Est. group size
~2
Recurring co-author estimate
Active years
38
Publishing since 1989
Typically publishes in teams of ~15 · 4% small-team papers (≤3 authors) · across 18 venues
- Cluster Randomized Controlled Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191
Hypertension · 2026
- Amyloid PET and clinical management in a diverse, cognitively impaired population: The New IDEAS Study
Alzheimer s & Dementia · 2025
- Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia
UNC Libraries · 2025
- Amyloid PET and changes in clinical management among ethnoracially diverse and clinically atypical individuals: Findings from New IDEAS
Alzheimer s & Dementia · 2025
- Amyloid PET and changes in clinical management among ethnoracially diverse and clinically atypical individuals: Findings from New IDEAS
Alzheimer s & Dementia · 2025
- Cigarette Smoking and Symptom Burden: Baseline Results From Nine ECOG-ACRIN Cancer Clinical Trials
Journal of Pain and Symptom Management · 2024
- Abstract PO3-19-03: Addressing USPSTF 2023 Identified Key Gaps in Knowledge in Breast Cancer Screening through TMIST (ECOG-ACRIN EA1151) or its Ancillary Studies
Cancer Research · 2024
- Clinical Impact of Amyloid PET in Diverse Medicare Beneficiaries with Cognitive Impairment: Preliminary Results from New IDEAS
Alzheimer s & Dementia · 2024
- Significant Incidental Findings in the National Lung Screening Trial
JAMA Internal Medicine · 2023
- Early Increases in Blood Pressure and Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma and Thyroid Cancer Treated With VEGFR TKIs
Journal of the National Comprehensive Cancer Network · 2023
- Amyloid Positron Emission Tomography and Subsequent Health Care Use Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
JAMA Neurology · 2023
- HYPERTENSION, CARDIOVASCULAR EVENTS AND SURVIVAL IN RENAL CELL CARCINOMA AND THYROID CANCER PATIENTS TREATED WITH VEGFR TYROSINE KINASE INHIBITORS
Journal of the American College of Cardiology · 2023
- Separating Actionable From Incidental Findings—Imperative for Meaningful Clinical Outcomes—Reply
JAMA Internal Medicine · 2023
- Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia
JAMA Neurology · 2022
- Neighborhood socioeconomic disadvantage, tobacco use, and cessation indicators among adults with cancer in the United States: Results from 10 ECOG-ACRIN trials.
Journal of Clinical Oncology · 2022
- Journal of Clinical Oncology×18
- UNC Libraries×7
- Alzheimer s & Dementia×6
- Cancer×5
- JAMA Oncology×4
- James L. Fisher
Medicine · The Ohio State University
- Samilia Obeng‐Gyasi
Medicine · The Ohio State University
- Michael L. Pennell
Medicine · The Ohio State University
- Oindrila Bhattacharyya
Medicine · The Ohio State University
- Archana Radhakrishnan
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile